Limited Use Note(s)

Government of Ontario Logo
QUINAGOLIDE HCL0.15mg Tab
Reason For Use CodeClinical Criteria
405For the treatment of hyperprolactinemia in patients who have: * Failed to respond to a greater than or equal to 3 month trial of bromocriptine; or * Failed to tolerate bromocriptine; or * Failed to shrink a prolactinoma by greater than 1 cm after 12 months of bromocriptine therapy
LU Authorization Period: 5 years.